In one of the interviews (I think it was Proactive), Dr T estimated that it would cost about 500M to conduct all those 40 x historical trials.
RAC inherits all that historical data for free.
And the MC is only 320M - undervalued.
Add to that the success of the AML clinical trial, pre-clinal breast cancer results, and City of Hope linking bisantrene to FTO, and you begin to see RAC being undervaled even further.
Heaps of upside to go...
RAC - Charts & Price Action, page-3403
-
- There are more pages in this discussion • 18,115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.80 |
Change
-0.005(0.28%) |
Mkt cap ! $306.5M | |||
| Open | High | Low | Value | Volume |
| $1.81 | $1.83 | $1.80 | $98.91K | 54.79K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 8267 | $1.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.82 | 500 | 1 |
View Market Depth
| Last trade - 14.33pm 28/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |